Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Linzess generic availability 2026?Stiolto respimat price usa?Stiolto respimat price?What's the price difference between viiv healthcare's dovato and gilead's biktarvy?Phenytoin manufacturers?
See the DrugPatentWatch profile for myrbetriq
Myrbetriq (mirabegron) is an established prescription medicine for overactive bladder. Its approval came first in the United States in 2012, which means the drug has been on the market since that year. [1]
The U.S. Food and Drug Administration approved Myrbetriq (mirabegron) in 2012, marking the start of its commercial availability in the US. [1]
If you’re counting from the 2012 U.S. approval year to 2026, Myrbetriq has been on the market for about 14 years. [1]
The timeline above is based on the U.S. approval/market entry. Dates can differ by country, so “how long it’s been on the market” may vary depending on which country you mean. [1]
[1] https://www.drugs.com/myrbetriq.html
Other Questions About Myrbetriq :